Stay updated on Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-20T00:00:00.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-13T05:53:10.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The study record history adds a new version documenting a study-status update, replacing an earlier listed date. The specific status change is not shown here.
    Difference
    0.1%
    Check dated 2026-10-05T23:45:20.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The study history now includes a new version entry for 2026-09-21 introducing Conditions and Study Status with Revision: v3.7.0, and the prior revision reference v3.6.6 dated 2026-08-04 was removed.
    Difference
    0.1%
    Check dated 2026-09-21T23:55:16.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous v3.6.5. This indicates a small update to the page's revision metadata.
    Difference
    0.0%
    Check dated 2026-08-31T18:52:49.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The study history was updated to add a new revision (v3.6.5) on 2026-08-04, introducing the Study Status and Contacts/Locations sections, and the prior revision (v3.6.4) from 2026-07-31 was removed.
    Difference
    0.1%
    Check dated 2026-08-10T11:53:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.